1993 Volume 86 Issue 7 Pages 1045-1051
Patients with head and neck cancer, especially squamous cell carcinoma, were divided into a UFT treated group (195 patients) and a contorol group (234 patients) after radical therapy. No difference was observed between the two groups.
Next we selected 155 pairs of patient from the two groups. The pairs had the same primary site and the same grade of disease.
UFT was shown to prolong the disease free period after radical therapy for squamous cell carcinoma of the mouth.